BRID

Business Context and Reporting Period

Company: Bridgford Foods Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: October 31, 2003
Business Overview: The Company operates in a single segment: the manufacture and distribution of frozen, refrigerated, and snack food products. Approximately 70% of sales are derived from products manufactured or processed by the Company, while 30% are purchased from third parties for resale. The Company serves both food service (restaurants, institutions) and retail customers across the United States and Canada.

Key Financial Metrics

Revenue and Profit (Unaudited Interim Data in thousands):
The filing provides quarterly breakdowns rather than a consolidated annual total in the text body. The following represents the fiscal year 2003 performance:

Valuation and Qualifying Accounts (Allowance for Doubtful Accounts):
Balance at beginning of period: $3,419 (in thousands)
Provision for losses: $915 (in thousands)
Accounts written off: $2,905 (in thousands)
Balance at close of period: $1,429 (in thousands)

Other Metrics:
The filing text does not provide clear consolidated annual values for total revenue, total profit, cash flow, margins, debt, or liquidity. These figures are incorporated by reference from the Annual Report to Shareholders.

Material Changes Versus Prior Period

• Reporting Structure: The Company changed its quarterly fiscal reporting periods starting in fiscal 2003. Previously, quarters were 13 weeks; the new structure utilizes 12-week quarters for the first three quarters and a 16-week fourth quarter to align with internal systems and peer comparisons.
• Performance Volatility: Fiscal 2003 showed significant volatility compared to Fiscal 2002. While Q1 2003 resulted in a net loss of $153,000, Q4 2003 (a 16-week period) generated a net income of $843,000. In contrast, Fiscal 2002 Q1 generated $1,552,000 in net income, but Q4 2002 resulted in a loss of $1,481,000.
• Customer Concentration: One customer accounted for approximately 14.6% of sales during fiscal 2003.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary and Outlook:
Management notes that sales are not subject to material seasonal variations. The Company has introduced new products, though none contributed significantly to revenue growth in the fiscal year. The Company does not maintain a significant sales backlog.

Risks and Contingencies:

• Regulatory Compliance: The Company is subject to strict USDA and FDA regulations, including the Hazard Analysis Critical Control Points (HACCP) program. New regulations regarding Listeria Monocytogenes took effect on October 6, 2003, requiring environmental and finished product testing. The Company believes it is in full compliance.
• Raw Materials: The Company purchases large quantities of commodity pork, beef, and flour. Prices fluctuate based on government programs, weather, and international trade policies.
• Key Personnel: The Company relies heavily on executive officers, particularly the Bridgford family. There are no employment or non-competition agreements with key personnel.
• Legal Proceedings: No material legal proceedings were pending as of October 31, 2003.

Unusual Items:
The filing does not explicitly detail unusual items in the text provided, though the allowance for doubtful accounts saw a significant provision ($915k) and write-off ($2,905k) during the year.

Important Facts for Investor Verification

• Consolidated Annual Totals: Verify the total annual net sales and net income for fiscal 2003 by reviewing the "Selected Financial Data" and "Consolidated Statements of Income" incorporated by reference from the Annual Report to Shareholders, as the 10-K text only provides quarterly breakdowns.
• Liquidity and Debt: Confirm the Company's current debt levels, cash position, and working capital ratios from the Consolidated Balance Sheets, as these specific figures are not present in the provided text.
• Customer Concentration: Assess the risk associated with the single customer representing 14.6% of sales and the potential impact of losing this account.
• Regulatory Testing Results: Monitor the impact of the new October 2003 Listeria testing regulations on product retention, recalls, or destruction costs.
• Equity Compensation: Note that 250,000 options are outstanding with a weighted-average exercise price of $10.00, with 650,000 shares remaining available for issuance under the 1999 Stock Incentive Plan.